Physician

Robert G Wilkins, MD

According to 2025 Medicare claims, Robert Wilkins, MD (NPI: 1598875304) practices interventional cardiology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39401-7246. Wilkins is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Wilkins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,940 traditional Medicare patients, billed 13,835 HCPCS/CPT codes, and received $1,087,774 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,576 prescription claims across 593 beneficiaries totaling $874,751 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 16 claims. Open Payments data shows 33 records totaling $2,742. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $203,964 to $874,751. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,121	10,029	$794,733
2016	3,574	10,912	$817,326
2017	1,980	9,930	$977,247
2018	1,996	9,271	$986,576
2019	2,184	8,770	$937,729
2020	1,648	7,043	$884,620
2021	1,791	11,798	$1,117,817
2022	2,077	11,388	$1,177,719
2023	2,043	15,535	$1,275,327
2024	1,940	13,835	$1,087,774

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	396	4,146	$203,964
2016	429	4,404	$270,242
2017	447	4,564	$382,109
2018	495	4,254	$440,603
2019	522	4,131	$486,240
2020	462	3,914	$587,237
2021	535	4,283	$658,662
2022	550	4,444	$812,100
2023	589	4,538	$911,231
2024	593	4,576	$874,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$726
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	16	$35,446
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	771	795	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	604	737	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	598	731	$11
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	705	825	$9
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	549	633	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	563	24,451	$485,840
Entresto	Sacubitril/Valsartan	174	6,945	$143,701
Xarelto	Rivaroxaban	114	4,380	$87,541
Brilinta	Ticagrelor	145	5,625	$80,223
Jardiance	Empagliflozin	20	1,200	$22,391

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$807	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$1,935	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert G. Wilkins, MD?

Tedicare shows public-source Medicare data for Robert G. Wilkins, MD (NPI 1598875304), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert G. Wilkins, MD have ACO affiliation data?

Robert G. Wilkins, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to Robert G. Wilkins, MD?

Robert G. Wilkins, MD is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Robert G. Wilkins, MD have Open Payments data?

Robert G. Wilkins, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.